Plus, manufacturing contracted in March, new mortgage applications fell, Fiat Chrysler reported a more than 10% decline in auto sales in the first quarter, and T-Mobile and Sprint finally completed their merger.
Read MorePlus, the $2 trillion stimulus bill has hit a snag in the House, the U.S. now has the most cases of the coronavirus in the world, and Novartis’ CEO said it’s “too soon” to say if two anti-malaria drugs will be an effective vaccine against the deadly virus.
Read MoreThe market hasn’t bottomed yet, but these are the key conditions to watch for.
Read MoreEconomists say we’re already coming into a recession. The question now is, will it get bad enough and last long enough to qualify as a depression?
Read MoreThe billionaire fund manager cashed out of market hedges this week to the tune of $2.6 billion, and used that cash to buy these 6 stocks.
Read MorePlus, the Senate passed its $2 trillion coronavirus stimulus package, deaths from COVID-19 surpassed 1,000 in the U.S., and Wendy’s withdrew guidance for the year.
Read MorePlus, 1 month and 3 month Treasury yields slipped into negative territory this morning, Target withdrew its full-year forecast, and Nike shares are rising after the sneaker maker reported better-than-expected sales.
Read MorePlus, the market is higher on optimism that a third stimulus bill will be finalized today, Gilead Sciences’ experimental COVID-19 treatment, remdesivir, received Orphan Drug Designation from the FDA, and General Motors said it is conserving cash and drawing down $16 billion from credit lines.
Read MorePlus, stocks’ volatile week continues, oil crashed to 18-year lows, and Apple announced new products.
Read MorePlus, the Trump administration is seeking a third coronavirus stimulus package, the WHO warns that the virus can in some cases survive in the air, and Cisco said that there have been 5.5 billion meeting minutes for its Webex video conferencing platform since the start of the month.
Read MoreWe could look back on March 2020 as the start of a recession in the U.S., according to big-name economist.
Read MorePlus, activity in the U.S. services sector accelerated in February, GE said the coronavirus will impact Q1 earnings, and Arcturus Therapeutics shares are on the rise after the company joins the quest to find a COVID-19 vaccine.
Read MorePlus, Pfizer announced it is initiating a program to screen antiviral drugs in its pipeline to identify possible treatments for the coronavirus, Target and Kohl’s reported earnings, and Thermo Fisher is buying Qiagen.
Read MorePlus, Coca-Cola warned the virus could dent first quarter earnings, Deere delivered an earnings beat, and online pet food supplier Chewy got an upgrade.
Read MorePlus, Tesla priced its secondary offering and issued a recall of its Model X SUVs in North America, and AstraZeneca posted plunging profits.
Read More